为临床药物试验建立护理质量评估指数系统:德尔菲研究
Junyi Chen1, Huiyu Zhou2, Qingxiu Mai1
1Phase I Clinical Trial Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Nursing open
|September 8, 2023
概括
开发了一种新的临床药物试验护理管理质量评估指数系统. 该系统包括3个第一级,12个第二级和59个第三级指标,用于评估护理质量和患者安全.
科学领域:
- 护理科学 护理科学
- 临床研究管理 临床研究管理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 有效的护理管理对于临床药物试验的质量和安全至关重要.
- 现有的评估系统可能无法充分捕捉护理在药物开发中的细微差别.
- 需要标准化的质量指标来监测和改进在这个专业领域的护理实践.
研究的目的:
- 在临床药物试验中构建一个全面的护理管理质量评估指数系统.
- 在建立的系统中确定每个指标的相对权重.
- 为评估,监测和改善临床药物试验中的护理质量提供一个框架.
主要方法:
- 采用混合方法的研究设计,主要是定性.
- 文献综述和半结构化访谈为开发专家咨询问卷提供了信息.
- 用了18名专家的德尔菲方法和分析层次分析来最终确定指标及其权重.
主要成果:
- 建立了一个质量评估系统,包括3个一级,12个二级和59个三级指标.
- 高的正系数 (90%-100%) 和权威系数 (0.831-0.885) 表示可靠的专家共识.
- 该系统的特点是清晰的水平,强大的临床可操作性和临床药物试验中的护理相关性.
结论:
- 建立的指数系统为评估,监测和提高临床药物试验中的护理质量提供了可靠的框架.
- 该系统阐明了护士对受试者安全和整体试验完整性的重要贡献.
- 这些发现为参与临床药物开发的医疗保健专业人员和研究人员提供了宝贵的参考资料.
相关概念视频
01:16Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:13Therapeutic Index
4.3K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.3K
01:15Nursing Evaluation
3.4K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.4K
01:27Nursing Clinical Information System
812
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
812
01:29Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.2K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.2K